Long-term results of a randomized trial of surgery with or without preoperative chemotherapy in esophageal cancer.

By W. Allum, S. Stenning, J. Bancewicz, P. Clark, R. Langley. Journal of Clinical Oncology, 2009

950 citations recorded by the source corpus.

Subfields: Oncology, Pulmonary and Respiratory Medicine, Surgery

View Paper: https://www.semanticscholar.org/paper/386844e2930d0b567c28fc7050f191c49b52a1a6

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

1. B. Nordlinger
2. W. Bechstein
3. K. Ott
4. E. Van Cutsem
5. M. Lutz
6. P. Reichardt
7. H. Wilke
8. M. Mauer

Citations in the corpus

• Neoadjuvant chemotherapy compared with surgery alone for locally advanced cancer of the stomach and cardia: European Organisation for Research and Treatment of Cancer randomized trial 40954. (2010, result): “0% in the 5-year survival rate.(16) The superior surgical outcome in our trial as compared with the other trials may be attributed at least in part to systematic preoperative overstaging.”
• A Randomized Trial Comparing Postoperative Adjuvant Chemotherapy with Cisplatin and 5-Fluorouracil Versus Preoperative Chemotherapy for Localized Advanced Squamous Cell Carcinoma of the Thoracic Esophagus (JCOG9907) (2011, neutral): “Concerning preoperative chemotherapy, a randomized controlled study in the UK demonstrated that preoperative chemotherapy was superior to surgery alone in overall survival in patients with esophageal carcinoma of any cell type.(5,6) On the other hand, another randomized study in the United States sh”